Hindustan Times ST (Jaipur)
PROBLEMS AT SERUM INSTITUTE LEAVE WORLD SHORT ON VACCINE
LONDON: Around the world, from Bangladesh to Nepal to Rwanda, vulnerable hotspots have been grappling with stalled Covid-19 vaccination programs as they run out of doses. Many of those shortages can be traced back to a single company: The Serum Institute of India.
The world’s largest vaccine maker, SII was last year named a top supplier of Covid shots to Covax, the World Health Organization-backed initiative aimed at securing an equitable global rollout. But the company has been dogged by setbacks, from a ban on exports to a factory fire, hampering its ability to fill orders.
SII’S travails have now become a key illustration of how the effort to inoculate against Covid has failed the developing world. The company has been unable to send any shots overseas since April, when India banned Covid vaccine exports amid the country’s devastating second wave. But some of its problems began long before.→p4